Heart health in young people with lupus
Part of Heart & circulation clinical trials.
This study looks at early signs of heart disease in children and teens with lupus. It may help doctors understand how lupus affects the heart and blood vessels over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 18 years old
- You have been diagnosed with juvenile lupus (JSLE)
- You have had lupus for at least 6 months
- You are being followed regularly at the study clinic
- You do not have other autoimmune diseases or heart problems
- You are not taking cholesterol-lowering medication
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using ultrasound to look at arteries in the neck can help prevent heart attacks and strokes in people with inflammatory joint diseases like rheumatoid arthritis or lupus. Researchers will use the results to guide treatment decisions.
This study looks at early heart function problems in children with lupus to find those at risk for severe disease. It may help doctors identify and treat severe lupus sooner.
This study looks at blood test results in children and teenagers with lupus to see if they relate to how active the disease is or if it has caused long-term damage. It may help doctors better understand the disease.
This study uses a simple blood test to estimate the risk of heart and blood vessel problems in people with lupus nephritis. It aims to find early signs of heart disease before symptoms appear.
This research study aims to better understand systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Researchers will evaluate patients with lupus, study genetic factors, and perform optional imaging tests to learn how the disease affects blood vessels and the heart.
This study looks at how the heart relaxes between beats (diastolic function) and measures certain blood markers of inflammation in people with lupus-related kidney disease who are in the intensive care unit (ICU). It aims to learn more about how lupus and inflammation affect the heart, which could lead to better treatment.
Hear when a new Atherosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.